Valuation

QIAQiagen N.V.

StockXetraGermanyHealth careEU retail: available

0.0% today · +11.6% over a year

9/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 78% of the instruments we score

Dividend yield 5.45%.

Qiagen N.V. (QIA) valuation against sector peers: P/E 25.6 (sector median 22.4), P/B 2.9, EV/EBIT 24.6, free-cash-flow yield 4.2%, P/S 5.2.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricQIASector medianvs median
P/E25.622.4 · n=2814% above
P/B2.93.6 · n=4519% below
P/S5.24.5 · n=4017% above
EV/EBIT24.620.8 · n=2818% above
Free-cash-flow yield4.2%3.5% · n=4120% above
Dividend yield5.45%0.12% · n=1004,465% above
Return on equity11.6%6.8% · n=5671% above
Return on invested capital9.1%7.0% · n=4729% above
Gross margin62.2%70.2% · n=3911% below
Net debt / EBITDA0.841.39 · n=2639% below

Value factor: 56 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

NVSNovartis AG21.36.517.95.9%2.5%9/10
NOVNNovartis AG21.26.417.85.9%2.9%10/10
AZNAstraZeneca plc25.75.420.94.5%1.9%6/10
AZNAstraZeneca PLC25.75.420.94.5%1.3%6/10
NVONovo Nordisk A/S11.25.99.85.2%4.8%7/10
GSKGSK plc13.84.811.38.1%3.7%10/10
SNYSanofi11.81.316.37.8%5.0%7/10
SANSanofi SA11.81.316.27.8%5.5%8/10
TEVATeva Pharmaceutical Industries Limited66.06.037.22.9%0.0%6/10
ALCAlcon34.71.527.35.1%0.4%4/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 20 Mar 2026